Trial intelligence / Profile preview

Calcium-D for Hypertension in Postmenopausal Women

NCT04618952Phase 4Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jan 2019
Primary completion
Aug 2020
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial in hypertension (HTN), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Mean systolic blood pressure in 24 hours at 60 days, Mean diastolic blood pressure in 24 hours at 60 days and 1 more. Started Jan 2019; status: completed.

02

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT04618952.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04618952.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call